The Role of M1/M2 Macrophage Polarization in Primary Sjogren's Syndrome

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2024 May 14

PMID 38745331

Authors

Xiaochan Chen

Linjiang Zhu

Huaxiang Wu

Affiliations

Soon will be listed here.

Abstract

Background: The purpose of this study was to investigate the role of macrophage polarization in the pathogenesis of primary Sjogren's syndrome (pSS).

Methods: Peripheral venous blood samples were collected from 30 patients with pSS and 30 healthy controls. Minor salivary gland samples were abtainted from 10 of these patients and 10 non-pSS controls whose minor salivary gland didn't fulfill the classification criteria for pSS. Enzyme-linked immuno sorbent assay was used to examine the serum concentration of M1/M2 macrophage related cytokines (TNF-a, IL-6, IL-23, IL-4, IL-10 and TGF-β). Flow cytometry was used to examine the numbers of CD86 M1 macrophages and CD206 M2 macrophages in peripheral blood mononuclear cells (PBMCs). Immunofluorescence was used to test the infiltration of macrophages in minor salivary glands.

Results: This study observed a significant increase in pSS patients both in the numbers of M1 macrophages in peripheral blood and serum levels of M1-related pro-inflammatory cytokines (IL-6, IL-23 and TNF-α). Conversely, M2 macrophages were downregulated in the peripheral blood of pSS patients. Similarly, in the minor salivary glands of pSS patients, the expression of M1 macrophages was increased, and that of M2 macrophages was decreased. Furthermore, a significantly positive correlation was found between the proportions of M1 macrophages in PBMCs and serum levels of IgG and RF.

Conclusions: This study reveals the presence of an significant imbalance in M1/M2 macrophages in pSS patients. The M1 polarization of macrophages may play an central role in the pathogenesis of pSS.

Citing Articles

Prevalence of hybrid TLR4M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease.

Gotelli E, Soldano S, Feghali-Bostwick C, Montagna P, Campitiello R, Contini P Front Immunol. 2024; 15:1488867.

PMID: 39635531 PMC: 11615060. DOI: 10.3389/fimmu.2024.1488867.

Possible involvement of Toll-like receptor 8-positive monocytes/macrophages in the pathogenesis of Sjögren's disease.

Yan L, Miyahara Y, Sakamoto M, Kaneko N, Chen H, Sameshima J Front Immunol. 2024; 15:1480675.

PMID: 39544932 PMC: 11560440. DOI: 10.3389/fimmu.2024.1480675.

Myeloid-derived growth factor promotes M2 macrophage polarization and attenuates Sjögren's syndrome via suppression of the CX3CL1/CX3CR1 axis.

Yang Z, Liu M, Chang Z, Du C, Yang Y, Zhang C Front Immunol. 2024; 15:1465938.

PMID: 39497829 PMC: 11532040. DOI: 10.3389/fimmu.2024.1465938.

References

Luo D, Li L, Wu Y, Yang Y, Ye Y, Hu J . Mitochondria-related genes and metabolic profiles of innate and adaptive immune cells in primary Sjögren's syndrome. Front Immunol. 2023; 14:1156774. PMC: 10366690. DOI: 10.3389/fimmu.2023.1156774. View

Muller E, Speth M, Christopoulos P, Lunde A, Avdagic A, Oynebraten I . Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation. Front Immunol. 2018; 9:2520. PMC: 6224375. DOI: 10.3389/fimmu.2018.02520. View

Lee K, Mun S, Kim S, Shin W, Jung W, Paek J . The inflammatory signature in monocytes of Sjögren's syndrome and systemic lupus erythematosus, revealed by the integrated Reactome and drug target analysis. Genes Genomics. 2022; 44(10):1215-1229. DOI: 10.1007/s13258-022-01308-y. View

Verstappen G, Kroese F, Bootsma H . T cells in primary Sjögren's syndrome: targets for early intervention. Rheumatology (Oxford). 2019; 60(7):3088-3098. PMC: 8516500. DOI: 10.1093/rheumatology/kez004. View

Ushio A, Arakaki R, Otsuka K, Yamada A, Tsunematsu T, Kudo Y . CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome. Front Immunol. 2018; 9:2594. PMC: 6236111. DOI: 10.3389/fimmu.2018.02594. View

Giron-Gonzalez J, Baturone R, Soto M, Marquez M, Macias I, Montes de Oca M . Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome. Cell Immunol. 2009; 259(1):56-60. DOI: 10.1016/j.cellimm.2009.05.013. View

Chen C, Liang Y, Zhang Z, Zhang Z, Yang Z . Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome. Int Immunopharmacol. 2020; 88:106878. DOI: 10.1016/j.intimp.2020.106878. View

Peng Y, Zhou M, Yang H, Qu R, Qiu Y, Hao J . Regulatory Mechanism of M1/M2 Macrophage Polarization in the Development of Autoimmune Diseases. Mediators Inflamm. 2023; 2023:8821610. PMC: 10270764. DOI: 10.1155/2023/8821610. View

Fogel O, Riviere E, Seror R, Nocturne G, Boudaoud S, Ly B . Role of the IL-12/IL-35 balance in patients with Sjögren syndrome. J Allergy Clin Immunol. 2017; 142(1):258-268.e5. DOI: 10.1016/j.jaci.2017.07.041. View

10.

Tao J, Zhao J, Qi X, Wu Y . Complement-mediated M2/M1 macrophage polarization may be involved in crescent formation in lupus nephritis. Int Immunopharmacol. 2021; 101(Pt A):108278. DOI: 10.1016/j.intimp.2021.108278. View

11.

Sica A, Mantovani A . Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012; 122(3):787-95. PMC: 3287223. DOI: 10.1172/JCI59643. View

12.

Zhao J, Kubo S, Nakayamada S, Shimajiri S, Zhang X, Yamaoka K . Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome. Mod Rheumatol. 2015; 26(5):716-24. DOI: 10.3109/14397595.2015.1129694. View

13.

Mohamed Ahamada M, Jia Y, Wu X . Macrophage Polarization and Plasticity in Systemic Lupus Erythematosus. Front Immunol. 2022; 12:734008. PMC: 8721097. DOI: 10.3389/fimmu.2021.734008. View

14.

Maslinska M, Paradowska-Gorycka A, Manczak M, Kostyra-Grabczak K, Kwiatkowska B . The level of TGF-β in sera of patients with primary Sjögren's syndrome. Reumatologia. 2020; 57(6):309-314. PMC: 7091483. DOI: 10.5114/reum.2019.91276. View

15.

Cutolo M, Campitiello R, Gotelli E, Soldano S . The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis. Front Immunol. 2022; 13:867260. PMC: 9161083. DOI: 10.3389/fimmu.2022.867260. View

16.

Zhou D, McNamara N . Macrophages: important players in primary Sjögren's syndrome?. Expert Rev Clin Immunol. 2014; 10(4):513-20. DOI: 10.1586/1744666X.2014.900441. View

17.

Mason G, Hamburger J, Bowman S, Matthews J . Salivary gland expression of transforming growth factor beta isoforms in Sjogren's syndrome and benign lymphoepithelial lesions. Mol Pathol. 2003; 56(1):52-9. PMC: 1187290. DOI: 10.1136/mp.56.1.52. View

18.

Zhou D, Chen Y, Chen F, Gallup M, Vijmasi T, Bahrami A . Critical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye. Am J Pathol. 2012; 181(3):753-60. PMC: 3432423. DOI: 10.1016/j.ajpath.2012.05.014. View

19.

Zong Y, Yang Y, Zhao J, Li L, Luo D, Hu J . Characterisation of macrophage infiltration and polarisation based on integrated transcriptomic and histological analyses in Primary Sjögren's syndrome. Front Immunol. 2023; 14:1292146. PMC: 10656691. DOI: 10.3389/fimmu.2023.1292146. View

20.

Li J, Yu Y, Liu C, Wang C . Significance of M2 macrophage in tubulointerstitial disease secondary to primary Sjogren's disease. Ren Fail. 2018; 40(1):634-639. PMC: 6225512. DOI: 10.1080/0886022X.2018.1518242. View